Search Videos and More

Showing 1 - 2 of 2 results

Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber/Boston Children's Team News

Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber/Boston Children's Team

An international team of clinical collaborators, led by physician scientists from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high-grade glioma.
Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium News

Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium, on February 13-15, 2025, in San Francisco, Calif.